1. Kiltz U, Perez-Ruiz F, Uhlig T et al (2018) The prevalence and incidence of gout, its associated comorbidities and treatment pattern: An epidemiological study from Germany. 2018 ACR/ARHP Annual Meeting, Chicago, 19.–24.10.2018 (abstract nr. 1131)
2. Zhu Y, Pandya BJ, Choi HK (2010) Prevalence of gout and hyperuricemia in the US general population: The National Health and Nutrition Examination Survey 2007–2008. Arthritis Rheum 63(10):3136–3141
3. Chen-Xu M, Yokose C, Pillinger M, Choi HK (2018) Contemporary prevalence of gout and hyperuricemia in the United States (National Health and Nutrition Examination Survey [NHANES] 2015–2016) and decadal trends (NHANES 2007–2016). 2018 ACR/ARHP Annual Meeting, Chicago, 19.–24.10.2018 (abstract nr. 1149)
4. Chen-Xu M, Yokose C, Pillinger M, Choi HK (2018) Prevalence of urate-lowering therapy use and target urate level achievement among gout patients in the United States (National Health And Nutrition Examination Survey [NHANES] 2007–2014). 2018 ACR/ARHP Annual Meeting, Chicago, 19.–24.10.2018 (abstract nr. 2237)
5. Chen-Xu M, Yokose C, Pillinger M, Choi HK (2018) Contemporary comorbidity burden of gout and hyperuricemia in the US during the past decade (National Health And Nutrition Examination Survey [NHANES] 2007–2016). 2018 ACR/ARHP Annual Meeting, Chicago, 19.–24.10.2018 (abstract nr. 2236)